Equity Brief · Healthcare2026-05-20
BSX·Healthcare

Boston Scientific Corp

Sentinellis health

6.3/10

Moderate concerns

Market capitalisation

$84.4B

Revenue (TTM)

$20.1B

§ I · AI Analysis

The brief

Boston Scientific designs and sells specialized medical equipment that doctors use during minimally-invasive procedures — think catheters, stents, implants, and electronic devices that treat conditions in the heart, digestive tract, urinary system, and nervous system [Boston Scientific]. Their products help cardiologists open blocked arteries, urologists treat bladder problems, and pain specialists manage chronic pain through implanted nerve stimulators [Boston Scientific].

Boston Scientific is a $84.4 billion medical device company that makes products for heart procedures, digestive system treatments, urology, and pain management [Yahoo Finance]. The company reported strong revenue growth of 19.9% year-over-year and recently announced a $2 billion share buyback alongside a $1.5 billion investment in MiRus, a company developing a new heart valve technology [Yahoo Finance]. Recent clinical trial success with its SEISMIQ 4CE device for treating severely calcified heart arteries positions the company well in a challenging cardiac niche [Simply Wall St].

Boston Scientific is financially stable with strong cash generation, though debt levels are moderate and returns on invested capital remain below 10% [Yahoo Finance].

Synthesis Claude Sonnet 4.5Confidence 8/10

§ II · Recent news

What moved

6 stories · ranked by relevance

  • macro2026-05-20

    Boston Scientific Trial Success Adds Weight To SEISMIQ 4CE And BSX Valuation

    Simply Wall St

  • macro2026-05-20

    Boston Scientific Corporation (BSX) Fell Due to Weak Results

    Yahoo Finance

  • macro2026-05-20

    Baird Maintains Bullish View on Boston Scientific (BSX) Despite Lower Target

    Yahoo Finance

  • macro2026-05-19

    Wall Street Bulls Look Optimistic About Boston Scientific (BSX): Should You Buy?

    Yahoo Finance

  • macro2026-05-19

    FRACTURE IDE trial of the Boston Scientific SEISMIQ™ 4CE Coronary Intravascular Lithotripsy Catheter meets primary safety and effectiveness endpoints

    Yahoo Finance

  • macro2026-05-18

    Boston Scientific announces strategic investment in MiRus LLC

    Yahoo Finance

Premium · Free with any account

Risk Analysis

Opportunities

Full Financials

Executive Team

Unlock the full Boston Scientific Corp analysis

Create a free account to access the complete AI-generated report with inline citations.

  • Risks, opportunities, and red flags with sources
  • 100+ financial metrics with charts and benchmarks
  • Full news summaries with source links
  • Executive team and compensation details
  • PDF export for offline use
Read my free brief3 free reports · No credit card

§ III · Related

You might also read

Same sector · Healthcare or comparable health

Want this for your watchlist?

Read three companies free. No card.

Get 3 free reports